BioCentury | Dec 30, 2016
Financial News

Rasna Therapeutics completes private placement

...shares at $0.60 in a private placement to accredited investors. Rasna Therapeutics Inc. (OTCQB:RASP), New York, N.Y. Alex Himes Rasna Therapeutics Inc....
BioCentury | Aug 22, 2016
Company News

Rasna, Active With Me deal

...Rasna reverse-merged with Active With Me. The combined company retained Rasna’s name and will focus on...
...a lead candidate identified by next year. Rasna did not respond in time for publication. Rasna Therapeutics Inc....
BioCentury | Jan 21, 2016
Finance

Italy's velocity factor

...year, the company facilitated a licensing agreement and collaboration between the IEO and London-based start-up Rasna...
...Colo. European Institute of Oncology (IEO), Milan, Italy FIRC Institute of Molecular Oncology, Milan, Italy Rasna...
BioCentury | Jan 14, 2016
Distillery Therapeutics

Therapeutics: Lysine-specific demethylase 1 (LSD1; KDM1A)

...AML and sarcoma. TARGET/MARKER/PATHWAY: Lysine-specific demethylase 1 (LSD1; KDM1A ) LICENSING STATUS: Patented; licensed to Rasna...
Items per page:
1 - 4 of 4
BioCentury | Dec 30, 2016
Financial News

Rasna Therapeutics completes private placement

...shares at $0.60 in a private placement to accredited investors. Rasna Therapeutics Inc. (OTCQB:RASP), New York, N.Y. Alex Himes Rasna Therapeutics Inc....
BioCentury | Aug 22, 2016
Company News

Rasna, Active With Me deal

...Rasna reverse-merged with Active With Me. The combined company retained Rasna’s name and will focus on...
...a lead candidate identified by next year. Rasna did not respond in time for publication. Rasna Therapeutics Inc....
BioCentury | Jan 21, 2016
Finance

Italy's velocity factor

...year, the company facilitated a licensing agreement and collaboration between the IEO and London-based start-up Rasna...
...Colo. European Institute of Oncology (IEO), Milan, Italy FIRC Institute of Molecular Oncology, Milan, Italy Rasna...
BioCentury | Jan 14, 2016
Distillery Therapeutics

Therapeutics: Lysine-specific demethylase 1 (LSD1; KDM1A)

...AML and sarcoma. TARGET/MARKER/PATHWAY: Lysine-specific demethylase 1 (LSD1; KDM1A ) LICENSING STATUS: Patented; licensed to Rasna...
Items per page:
1 - 4 of 4